FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma

Detalhes bibliográficos
Principais autores:	Couillard, S, Shrimanker, R, Chaudhuri, R, Mansur, AH, McGarvey, LP, Heaney, LG, Fowler, SJ, Bradding, P, Pavord, ID, Hinks, TSC
Formato:	Conference item
Idioma:	English
Publicado em:	BMJ Publishing Group 2021

Registros relacionados